| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.0009 |
1 |
| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.001 |
1 |
| mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.0007 |
1 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.00045 |
1 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.00028 |
1 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.00025 |
1 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00019 |
1 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
6.1e-05 |
1 |
| mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
4.3e-05 |
1 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-2.6e-05 |
1 |